search
Back to results

Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise

Primary Purpose

Coronary Heart Disease, Cardiovascular Risk Factor, Arterial Stiffness

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Exercise
Sponsored by
Loughborough University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Coronary Heart Disease

Eligibility Criteria

18 Years - 45 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • 18 to 45-year-old men;
  • Be able to run continuously for 1 hour;
  • Body mass index between 18.5 and 29.9 kg/m2;
  • No known contradictions to maximal exertion exercise (e.g., recent musculoskeletal injury, congenital heart disease).

Exclusion Criteria:

  • Musculoskeletal injury that has affected normal ambulation within the last month;
  • Uncontrolled exercise-induced asthma;
  • Coagulation or bleeding disorders;
  • Heart conditions;
  • Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
  • Taking any medication that might influence fat metabolism, blood glucose or appetite;
  • Smoking (including vaping);
  • Dieting or restrained eating behaviours;
  • Weight fluctuation greater than 3 kg in the previous 3 months to study enrolment;
  • Presence of any diagnosed sleeping disorder;
  • A food allergy.

Sites / Locations

  • Loughborough University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

No Intervention

Experimental

Experimental

Arm Label

Control 1

Control 2

Exercise 1

Exercise 2

Arm Description

Participants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Participants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Participants will complete 60 min of treadmill exercise on day 1 (15:15-16:15). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Participants will complete 60 min of treadmill exercise on day 1 (15:15-16:15). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Outcomes

Primary Outcome Measures

Plasma triacylglycerol concentration
Fasted plasma triacylglycerol concentration on day 1 and day 2. Time-averaged total area under the curve for triacylglycerol on day 2 in response to exercise and/or feeding.

Secondary Outcome Measures

Plasma glucose concentration
Fasted plasma glucose concentration on day 1 and day 2. Time-averaged total area under the curve for glucose on day 2 in response to exercise and/or feeding.
Plasma insulin concentration
Fasted plasma insulin concentration on day 1 and day 2. Time-averaged total area under the curve for insulin on day 2 in response to exercise and/or feeding.
Plasma total cholesterol concentration
Fasted plasma total cholesterol concentration on day 1 and day 2.
Plasma high-density lipoprotein cholesterol concentration
Fasted plasma high-density lipoprotein cholesterol concentration on day 1 and day 2.
Plasma low-density lipoprotein cholesterol concentration
Fasted plasma low-density lipoprotein cholesterol concentration on day 1 and day 2.
Plasma C-reactive protein concentration
Fasted plasma C-reactive protein concentration on day 1 and day 2.
Apolipoprotein E
Apolipoprotein E genotype at baseline.
Resting arterial blood pressure
Fasted resting systolic and diastolic blood pressure on day 1 and day 2. Time-averaged total area under the curve for systolic and diastolic blood pressure on day 2 in response to exercise and/or feeding.
Resting pulse wave analysis
Time-course of resting pulse wave analysis in response to exercise and/or feeding on day 1 and day 2.
Resting pulse wave velocity
Time-course of resting pulse wave velocity in response to exercise and/or feeding on day 1 and day 2.
Time in bed
Total time in bed between 'lights out' to 'lights on'.
Total sleep time
Total time asleep between 'lights out' to 'lights on'.
Actual wake time
Total time awake after the first sleep period.
Sleep onset latency
Total time from 'lights out' to the first sleep epoch.
Sleep efficiency
Total sleep time expressed as a percentage of time in bed.
Sleep fragmentation index
Number of times that sleep is terminated after one minute expressed as a percentage of the total sleep time.

Full Information

First Posted
August 20, 2021
Last Updated
August 16, 2022
Sponsor
Loughborough University
Collaborators
Teesside University
search

1. Study Identification

Unique Protocol Identification Number
NCT05022498
Brief Title
Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise
Official Title
A Replicated Crossover Study Exploring Individual Variability of Postprandial Coronary Heart Disease Risk Markers and Sleep Quality in Response to Acute Exercise in Healthy Young Men
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
July 13, 2021 (Actual)
Study Completion Date
July 13, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Loughborough University
Collaborators
Teesside University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to examine the reproducibility of postprandial coronary heart disease (CHD) risk marker and sleep responses to acute exercise bouts and to quantify the magnitude of individual variability in responses using a replicated crossover design. Healthy, recreationally active men will complete two identical rest control and two identical exercise (60 min at 60% maximum oxygen uptake) conditions in randomised sequences. Fasting and postprandial venous blood samples, arterial blood pressure and arterial stiffness measurements will be taken at pre-determined intervals, and sleep duration and quality will be assessed. Reproducibility and individual variability will be examined using bivariate correlations and linear mixed modelling.
Detailed Description
Single bouts of exercise reduce circulating concentrations of postprandial triacylglycerol - an established independent risk marker for coronary heart disease (CHD). The exercise-induced reduction in postprandial triacylglycerol concentrations has been shown to coincide with transient changes in other CHD risk markers, including reductions in postprandial insulin, interleukin-6, arterial stiffness and resting arterial blood pressure, and exercise may also promote sleep duration and quality. Individual variability in these responses is suspected but has not been examined using robust designs and appropriate statistical models. A recent approach to quantify individual variability in the intervention response involves quantifying the participant-by-condition interaction from replicated intervention and comparator arms. Using this approach (the replicated crossover design), the present study will (i) examine whether the postprandial CHD risk marker and sleep responses to acute exercise are reproducible on repeated occasions; and (ii) determine whether there is true individual variability in postprandial CHD risk marker and sleep responses to acute exercise. A total of 20 healthy, recreationally active men will be recruited. Participants will undertake a preliminary measures visit (visit 1) to confirm eligibility, to undergo anthropometric measurements and to determine maximum oxygen uptake. Participants will complete four, 2-day experimental conditions in randomised sequences separated by at least one week: two identical control and two identical exercise conditions. On day 1 (visits 2, 4, 6 and 8), participants will arrive fasted at 08:00 and a baseline blood sample, blood pressure and arterial stiffness measurement will be taken. Participants will consume a standardised high fat breakfast at 08:45 (0 h) and lunch at 12:45 (4 h). A second arterial stiffness measurement will be taken at 16:45 (8 h). The two control and two exercise conditions will be identical, except that participants will be asked to exercise on the treadmill for 60 minutes at 60% of their maximum oxygen uptake at 15:15 (6.5 h) in both exercise conditions. On day 2 (visits 3, 5, 7 and 9), participants will arrive fasted at 08:00 and will rest in the laboratory throughout the day in the two control and two exercise conditions. Participants will consume a standardised breakfast at 08:45 (0 h) and a standardised lunch at 12:45 (4 h). Venous blood samples will be collected at 0, 0.5, 1, 2, 3, 4, 4.5, 5, 6, 7 and 8 h. Resting arterial blood pressure will be measured at hourly intervals. Arterial stiffness will be measured at 0, 2.5 and 5 h. Sleep duration and quality will be assessed for three nights before and two nights after visits 3, 5, 7 and 9 using a triaxial actigraphy watch. Reproducibility and individual variability will be explored by correlating the two sets of response differences between exercise and control conditions. Within-participant covariate-adjusted linear mixed models will be used to quantify participant-by-condition interactions. It is hypothesised that (i) control-adjusted postprandial CHD risk marker and sleep responses to acute exercise will be reproducible; and (ii) true interindividual variability will exist in postprandial CHD risk marker and sleep responses to acute exercise beyond any random within-subject variation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Heart Disease, Cardiovascular Risk Factor, Arterial Stiffness, Blood Pressure, Sleep

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control 1
Arm Type
No Intervention
Arm Description
Participants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Arm Title
Control 2
Arm Type
No Intervention
Arm Description
Participants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Arm Title
Exercise 1
Arm Type
Experimental
Arm Description
Participants will complete 60 min of treadmill exercise on day 1 (15:15-16:15). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Arm Title
Exercise 2
Arm Type
Experimental
Arm Description
Participants will complete 60 min of treadmill exercise on day 1 (15:15-16:15). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
60 min treadmill exercise performed at 60% of maximum oxygen uptake.
Primary Outcome Measure Information:
Title
Plasma triacylglycerol concentration
Description
Fasted plasma triacylglycerol concentration on day 1 and day 2. Time-averaged total area under the curve for triacylglycerol on day 2 in response to exercise and/or feeding.
Time Frame
Day 1: fasted; Day 2: fasted (0 hours), 0.5 hours, 1 hours, 2 hours, 3 hours, 4 hours, 4.5 hours, 5 hours, 6 hours, 7 hours and 8 hours
Secondary Outcome Measure Information:
Title
Plasma glucose concentration
Description
Fasted plasma glucose concentration on day 1 and day 2. Time-averaged total area under the curve for glucose on day 2 in response to exercise and/or feeding.
Time Frame
Day 1: fasted; Day 2: fasted (0 hours), 0.5 hours, 1 hours, 2 hours, 3 hours, 4 hours, 4.5 hours, 5 hours, 6 hours, 7 hours and 8 hours
Title
Plasma insulin concentration
Description
Fasted plasma insulin concentration on day 1 and day 2. Time-averaged total area under the curve for insulin on day 2 in response to exercise and/or feeding.
Time Frame
Day 1: fasted; Day 2: fasted (0 hours), 0.5 hours, 1 hours, 2 hours, 3 hours, 4 hours, 4.5 hours, 5 hours, 6 hours, 7 hours and 8 hours
Title
Plasma total cholesterol concentration
Description
Fasted plasma total cholesterol concentration on day 1 and day 2.
Time Frame
Day 1: fasted; Day 2: fasted
Title
Plasma high-density lipoprotein cholesterol concentration
Description
Fasted plasma high-density lipoprotein cholesterol concentration on day 1 and day 2.
Time Frame
Day 1: fasted; Day 2: fasted
Title
Plasma low-density lipoprotein cholesterol concentration
Description
Fasted plasma low-density lipoprotein cholesterol concentration on day 1 and day 2.
Time Frame
Day 1: fasted; Day 2: fasted
Title
Plasma C-reactive protein concentration
Description
Fasted plasma C-reactive protein concentration on day 1 and day 2.
Time Frame
Day 1: fasted; Day 2: fasted
Title
Apolipoprotein E
Description
Apolipoprotein E genotype at baseline.
Time Frame
Day 1: fasted (baseline)
Title
Resting arterial blood pressure
Description
Fasted resting systolic and diastolic blood pressure on day 1 and day 2. Time-averaged total area under the curve for systolic and diastolic blood pressure on day 2 in response to exercise and/or feeding.
Time Frame
Day 1: fasted; Day 2: fasted (0 hours), 1 hours, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours and 8 hours
Title
Resting pulse wave analysis
Description
Time-course of resting pulse wave analysis in response to exercise and/or feeding on day 1 and day 2.
Time Frame
Day 1: fasted (0 hours), 8 hours; Day 2: fasted (0 hours), 2.5 hours, 5 hours.
Title
Resting pulse wave velocity
Description
Time-course of resting pulse wave velocity in response to exercise and/or feeding on day 1 and day 2.
Time Frame
Day 1: fasted (0 hours), 8 hours; Day 2: fasted (0 hours), 2.5 hours, 5 hours.
Title
Time in bed
Description
Total time in bed between 'lights out' to 'lights on'.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)
Title
Total sleep time
Description
Total time asleep between 'lights out' to 'lights on'.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)
Title
Actual wake time
Description
Total time awake after the first sleep period.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)
Title
Sleep onset latency
Description
Total time from 'lights out' to the first sleep epoch.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)
Title
Sleep efficiency
Description
Total sleep time expressed as a percentage of time in bed.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)
Title
Sleep fragmentation index
Description
Number of times that sleep is terminated after one minute expressed as a percentage of the total sleep time.
Time Frame
20 nights (5 nights per condition; three nights before and two nights after visits 3, 5, 7 and 9)

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 to 45-year-old men; Be able to run continuously for 1 hour; Body mass index between 18.5 and 29.9 kg/m2; No known contradictions to maximal exertion exercise (e.g., recent musculoskeletal injury, congenital heart disease). Exclusion Criteria: Musculoskeletal injury that has affected normal ambulation within the last month; Uncontrolled exercise-induced asthma; Coagulation or bleeding disorders; Heart conditions; Diabetes (metabolism will be different to non-diabetics potentially skewing the data); Taking any medication that might influence fat metabolism, blood glucose or appetite; Smoking (including vaping); Dieting or restrained eating behaviours; Weight fluctuation greater than 3 kg in the previous 3 months to study enrolment; Presence of any diagnosed sleeping disorder; A food allergy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Stensel
Organizational Affiliation
Loughborough University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Loughborough University
City
Loughborough
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymised individual participant data for all primary and secondary outcome measures will be made available upon request.
Citations:
PubMed Identifier
24201708
Citation
Freese EC, Gist NH, Cureton KJ. Effect of prior exercise on postprandial lipemia: an updated quantitative review. J Appl Physiol (1985). 2014 Jan 1;116(1):67-75. doi: 10.1152/japplphysiol.00623.2013. Epub 2013 Nov 7.
Results Reference
background
PubMed Identifier
25333969
Citation
Ashor AW, Lara J, Siervo M, Celis-Morales C, Mathers JC. Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014 Oct 15;9(10):e110034. doi: 10.1371/journal.pone.0110034. eCollection 2014.
Results Reference
background
PubMed Identifier
25596964
Citation
Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. J Behav Med. 2015 Jun;38(3):427-49. doi: 10.1007/s10865-015-9617-6. Epub 2015 Jan 18.
Results Reference
background
PubMed Identifier
29240652
Citation
Goltz FR, Thackray AE, King JA, Dorling JL, Atkinson G, Stensel DJ. Interindividual Responses of Appetite to Acute Exercise: A Replicated Crossover Study. Med Sci Sports Exerc. 2018 Apr;50(4):758-768. doi: 10.1249/MSS.0000000000001504.
Results Reference
background
PubMed Identifier
31132105
Citation
Goltz FR, Thackray AE, Atkinson G, Lolli L, King JA, Dorling JL, Dowejko M, Mastana S, Stensel DJ. True Interindividual Variability Exists in Postprandial Appetite Responses in Healthy Men But Is Not Moderated by the FTO Genotype. J Nutr. 2019 Jul 1;149(7):1159-1169. doi: 10.1093/jn/nxz062.
Results Reference
background
PubMed Identifier
25823596
Citation
Atkinson G, Batterham AM. True and false interindividual differences in the physiological response to an intervention. Exp Physiol. 2015 Jun;100(6):577-88. doi: 10.1113/EP085070. Epub 2015 May 13.
Results Reference
background
PubMed Identifier
20739334
Citation
Senn S, Rolfe K, Julious SA. Investigating variability in patient response to treatment--a case study from a replicate cross-over study. Stat Methods Med Res. 2011 Dec;20(6):657-66. doi: 10.1177/0962280210379174. Epub 2010 Aug 25.
Results Reference
background
PubMed Identifier
26415869
Citation
Senn S. Mastering variation: variance components and personalised medicine. Stat Med. 2016 Mar 30;35(7):966-77. doi: 10.1002/sim.6739. Epub 2015 Sep 28.
Results Reference
background

Learn more about this trial

Individual Variability of Coronary Heart Disease Risk Markers and Sleep Responses to Exercise

We'll reach out to this number within 24 hrs